Fumiyasu Hanamura

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

A multicenter Phase II study of mFOLFOX6 plus nivolumab for gastric cancer with severe peritoneal metastases: WJOG16322G.

A multicenter Phase II study of mFOLFOX6 plus nivolumab for gastric cancer with severe peritoneal metastases: WJOG16322G.

Journal: Future oncology (London, England)

Published: June 06, 2025

Liquid biopsy for breast cancer and other solid tumors: a review of recent advances.

Liquid biopsy for breast cancer and other solid tumors: a review of recent advances.

Journal: Breast cancer (Tokyo, Japan)

Published: October 26, 2023

Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study.

Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study.

Journal: Targeted oncology

Published: August 22, 2023

Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.

Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.

Journal: BMC cancer

Published: August 05, 2023

Survival in Older Japanese Adults With Advanced Cancer Before and After Implementation of a Geriatric Oncology Service.

Survival in Older Japanese Adults With Advanced Cancer Before and After Implementation of a Geriatric Oncology Service.

Journal: JCO oncology practice

Published: May 18, 2023

RHAMM marks proliferative subpopulation of human colorectal cancer stem cells.

RHAMM marks proliferative subpopulation of human colorectal cancer stem cells.

Journal: Cancer science

Published: November 15, 2022

Thrombocytopenia Caused by Dexamethasone in a Patient with Colorectal Cancer.

Thrombocytopenia Caused by Dexamethasone in a Patient with Colorectal Cancer.

Journal: Internal medicine (Tokyo, Japan)

Published: October 15, 2020

Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin.

Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin.

Journal: Scientific reports

Published: June 08, 2020

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.

Journal: British journal of cancer

Published: October 28, 2019

Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer.

Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer.

Journal: Oncoimmunology

Published: July 25, 2019

Epithelial-mesenchymal transition is activated in CD44-positive malignant ascites tumor cells of gastrointestinal cancer.

Epithelial-mesenchymal transition is activated in CD44-positive malignant ascites tumor cells of gastrointestinal cancer.

Journal: Cancer science

Published: April 04, 2018

PD-1+ TIM-3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer.

PD-1+ TIM-3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer.

Journal: Cancer science

Published: March 01, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026